Morphic Holding Inc

NASDAQ:MORF   3:59:50 PM EDT
57.50
+3.24 (+5.97%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)2.07B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$7.83 Million
Adjusted EPS-$0.55
See more estimates
10-Day MAN/A
50-Day MAN/A
200-Day MAN/A
See more pivots

Morphic Holding Inc Stock, NASDAQ:MORF

35 Gatehouse Drive A2, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.996.0955
Number of Employees: 89

Description

Morphic Holding, Inc. operates as a biopharmaceutical company, which engages in the research and development of oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.